Mindray Medical International (NYSE: MR) and Pacific Biosciences of California (NASDAQ:PACB) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Profitability

This table compares Mindray Medical International and Pacific Biosciences of California’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mindray Medical International 15.93% 12.70% 8.37%
Pacific Biosciences of California -89.67% -93.31% -57.10%

Valuation and Earnings

This table compares Mindray Medical International and Pacific Biosciences of California’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Mindray Medical International N/A N/A N/A N/A N/A
Pacific Biosciences of California $95.83 million 5.87 -$75.40 million ($0.92) -5.29

Mindray Medical International has higher revenue, but lower earnings than Pacific Biosciences of California.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Mindray Medical International and Pacific Biosciences of California, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mindray Medical International 0 0 0 0 N/A
Pacific Biosciences of California 0 2 1 0 2.33

Pacific Biosciences of California has a consensus target price of $8.93, indicating a potential upside of 83.44%. Given Pacific Biosciences of California’s higher possible upside, analysts plainly believe Pacific Biosciences of California is more favorable than Mindray Medical International.

Insider & Institutional Ownership

68.3% of Pacific Biosciences of California shares are owned by institutional investors. 17.8% of Pacific Biosciences of California shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pacific Biosciences of California beats Mindray Medical International on 5 of the 8 factors compared between the two stocks.

Mindray Medical International Company Profile

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Pacific Biosciences of California Company Profile

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Receive News & Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.